The store will not work correctly when cookies are disabled.
2-(1H-Benzoimidazole-2-sulfinylmethyl)-4-chloro-phenylamine
ID: ALA279086
PubChem CID: 14064689
Max Phase: Preclinical
Molecular Formula: C14H12ClN3OS
Molecular Weight: 305.79
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccc(Cl)cc1C[S+]([O-])c1nc2ccccc2[nH]1
Standard InChI: InChI=1S/C14H12ClN3OS/c15-10-5-6-11(16)9(7-10)8-20(19)14-17-12-3-1-2-4-13(12)18-14/h1-7H,8,16H2,(H,17,18)
Standard InChI Key: ZJGQPJPPHVKIGR-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
5.1349 -3.3975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2244 -4.2294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8956 -3.0632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4168 -2.9813 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.9797 -2.9865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0387 -4.3961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6978 -3.4027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4549 -3.6781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2684 -3.4027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9873 -2.1624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4130 -2.1602 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5518 -2.9923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2692 -1.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2789 -4.2373 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5486 -2.1619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2697 -0.9179 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.4544 -5.1168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2868 -3.6806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2868 -5.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7031 -4.3919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 7 1 0
6 2 1 0
7 4 1 0
8 3 1 0
9 5 1 0
10 5 2 0
11 4 1 0
12 9 2 0
13 10 1 0
14 9 1 0
15 13 2 0
16 13 1 0
17 6 2 0
18 8 2 0
19 17 1 0
20 18 1 0
6 8 1 0
19 20 2 0
12 15 1 0
M CHG 2 4 1 11 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 305.79 | Molecular Weight (Monoisotopic): 305.0390 | AlogP: 3.11 | #Rotatable Bonds: 3 |
Polar Surface Area: 77.76 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.36 | CX Basic pKa: 2.76 | CX LogP: 2.33 | CX LogD: 2.32 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.58 | Np Likeness Score: -0.90 |
References
1. Adelstein GW, Yen CH, Haack RA, Yu S, Gullikson G, Price DV, Anglin C, Decktor DL, Tsai H, Keith RH.. (1988) Substituted 2-[(2-benzimidazolylsulfinyl)methyl]anilines as potential inhibitors of H+/K+ ATPase., 31 (6): [PMID:2836591] [10.1021/jm00401a024] |